Balance Sheet Data

TG Therapeutics, Inc. (TGTX)

$13.32

-0.12 (-0.89%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 68.81140.43605.43350.30174.0867,729.691,504,375.7033,414,391.31742,182,652.4716,484,965,552.75
Total Cash (%)
Account Receivables 0.100.100.104.181.7438.66858.7419,073.79423,656.819,410,039.39
Account Receivables (%)
Inventories 9.699.699.69426.47177.563,943.9187,600.121,945,727.1543,217,454.63959,923,070.70
Inventories (%)
Accounts Payable ----0.4642.02464.5410,318.09229,179.825,090,420.01113,065,696.52
Accounts Payable (%)
Capital Expenditure -0.09-0.13-0.36-0.40-0.01-47.85-1,062.80-23,606.38-524,332.27-11,646,189.05
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.